GPR52-MODULATORVERBINDUNGEN

Patent europeic · EP4055016 · En vigur

Inscripziun en il register

Numer da publicaziun
EP4055016
Numer da la dumonda
EP20804658
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
09-11-2020
Publitgà
14-09-2022
Concedì
29-04-2026
La protecziun finescha il pli tard
08-11-2040
Proxima taxa annuala scadenta
30-11-2026
Classas IPC
C07D 471/04 (2006.01)
C07D 487/04 (2006.01)
C07D 498/04 (2006.01)
A61P 25/18 (2006.01)
A61K 31/437 (2006.01)
Prioritad
GB 201916298 08.11.2019
GB 201918974 20.12.2019
GB 201918992 20.12.2019
Dumonda PCT
PCT/GB2020/052832 09.11.2020
Publicaziun PCT
WO2021/090030 14.05.2021
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 05-05-2026

    Represchentant inscrit

    Representative
    BOVARD AG, Optingenstrasse 16, 3013 Bern

    Published in Swissreg on 05.05.2026

  2. 29-04-2026

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 29.04.2026

Partidas

Possessur

Nxera Pharma UK Limited

Granta Park Great Abington, Cambridge, Cambridgeshire CB21 6DG, GB

Represchentant

Bovard AG

BOVARD AG

Optingenstrasse 16, 3013 Bern

Inventur

BUCKNELL, Sarah Joanne

Cambridge Cambridgeshire CB21 6DG, GB

WATSON, Stephen Paul

Cambridge Cambridgeshire CB21 6DG, GB

O'BRIEN, Michael Alistair

Cambridge Cambridgeshire CB21 6DG, GB

DE GRAAF, Chris

Cambridge Cambridgeshire CB21 6DG, GB

SWAIN, Nigel Alan

Cambridge Cambridgeshire CB21 6DG, GB

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.